WO1989006974A3 - Epitopes de cellules t a titre de molecules porteuses pour vaccins conjugues - Google Patents
Epitopes de cellules t a titre de molecules porteuses pour vaccins conjugues Download PDFInfo
- Publication number
- WO1989006974A3 WO1989006974A3 PCT/US1989/000388 US8900388W WO8906974A3 WO 1989006974 A3 WO1989006974 A3 WO 1989006974A3 US 8900388 W US8900388 W US 8900388W WO 8906974 A3 WO8906974 A3 WO 8906974A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- conjugate vaccines
- conjugates
- cell epitope
- epitopes
- carriers molecule
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP89908669A EP0399001B1 (fr) | 1988-02-01 | 1989-01-31 | Epitopes de cellules t a titre de molecules porteuses pour vaccins conjugues |
DE68917126T DE68917126T2 (de) | 1988-02-01 | 1989-01-31 | T-zellen-epitope als träger für einen konjugierten impfstoff. |
FI903292A FI104374B (fi) | 1988-02-01 | 1990-06-29 | T-solu-epitooppi-oligopeptidejä ja niitä sisältävien konjugaattien valmistus |
NO902909A NO179164C (no) | 1988-02-01 | 1990-06-29 | Fremgangsmåte for fremstilling av et immunogenkonjugat |
DK199001829A DK174416B1 (da) | 1988-02-01 | 1990-07-31 | Oligopeptider, immunogene konjugater heraf med et antigen samt vacciner indeholdende disse konjugater |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15068888A | 1988-02-01 | 1988-02-01 | |
US150,688 | 1988-02-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1989006974A2 WO1989006974A2 (fr) | 1989-08-10 |
WO1989006974A3 true WO1989006974A3 (fr) | 1989-08-24 |
Family
ID=22535596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1989/000388 WO1989006974A2 (fr) | 1988-02-01 | 1989-01-31 | Epitopes de cellules t a titre de molecules porteuses pour vaccins conjugues |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0399001B1 (fr) |
JP (1) | JP2921574B2 (fr) |
AT (1) | ATE109008T1 (fr) |
AU (1) | AU634153B2 (fr) |
CA (2) | CA1340958C (fr) |
DE (1) | DE68917126T2 (fr) |
DK (1) | DK174416B1 (fr) |
FI (1) | FI104374B (fr) |
NO (1) | NO179164C (fr) |
WO (1) | WO1989006974A2 (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69032484T4 (de) * | 1989-10-27 | 1999-09-16 | Arch Dev Corp | Zusammensetzungen und deren verwendung zur förderung der immunopotentiation |
GB8924438D0 (en) * | 1989-10-31 | 1989-12-20 | Hoffmann La Roche | Vaccine composition |
US5500366A (en) * | 1990-09-18 | 1996-03-19 | Biotech Australia Pty. Ltd. | Polynucleotide encoding T-cell epitopes of the protein TraT |
WO1993011157A1 (fr) * | 1991-11-27 | 1993-06-10 | The Council Of The Queensland Institute Of Medical Research | VACCIN ET PEPTIDES CONTRE LA MALARIA COMPRENANT UN EPITOPE DE CELLULE T HUMAINE DE PROTEINE CIRCUMSPOROZOITE DE $i(P.VIVAX) |
IL105503A (en) * | 1992-04-28 | 1999-05-09 | Astra Ab | Carbon peptide couplets capable of eliciting an immune response of T cells |
IL106436A0 (en) * | 1992-07-22 | 1993-11-15 | Proteus Molecular Design | Synthetic polypeptides and their use |
ATE174628T1 (de) * | 1992-07-31 | 1999-01-15 | Medeva Holdings Bv | Expression rekombinanter fusionsproteine in attenuierten bakterien |
ATE258188T1 (de) | 1992-08-27 | 2004-02-15 | Deakin Res Ltd | Retro-, inverso-, und retro-inverso synthetische peptidanaloge |
DK140992D0 (da) * | 1992-11-24 | 1992-11-24 | Ole Buchardt | Fremgangsmaade til frembringelse af antistoffer mod haptener og andre b-celle-antigener, antistoffer opnaaet ved fremgangsmaaden og anvendelse af disse antistoffer til fremstilling af vacciner, isaer til veterinaermedicinsk brug |
US5759551A (en) * | 1993-04-27 | 1998-06-02 | United Biomedical, Inc. | Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines |
GB9401787D0 (en) | 1994-01-31 | 1994-03-23 | Medeva Holdings Bv | Vaccine compositions |
AU7235794A (en) * | 1993-07-30 | 1995-02-28 | Medeva Holdings B.V. | Vaccine compositions |
GB9401795D0 (en) * | 1994-01-31 | 1994-03-23 | Medeva Holdings Bv | Vaccines |
GB2295394B (en) * | 1994-01-31 | 1997-09-24 | Medeva Holdings Bv | DNA encoding a fusion protein comprising the C fragment of tetanus toxin |
WO1995024216A1 (fr) * | 1994-03-07 | 1995-09-14 | Auckland Uniservices Limited | Prevention du diabete |
US5840307A (en) * | 1995-03-31 | 1998-11-24 | Immulogic Pharmacuetical Corp. | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation |
DE69637089T2 (de) * | 1995-03-31 | 2008-01-17 | Xenova Research Ltd., Slough | Hapten-Träger-Konjugate zur Anwendung in der Drogen-Missbrauchs-Therapie |
US5843462A (en) * | 1995-11-30 | 1998-12-01 | Regents Of The University Of Minnesota | Diphtheria toxin epitopes |
US7709002B1 (en) | 1996-04-19 | 2010-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes |
ATE220718T1 (de) | 1996-04-19 | 2002-08-15 | Us Gov Sec Health | Mutierte ras peptide zur zeugung von cd8+ zytitoxischen t lymphoizyten |
GB9713156D0 (en) * | 1997-06-20 | 1997-08-27 | Microbiological Res Authority | Vaccines |
TWI229679B (en) | 1998-06-20 | 2005-03-21 | United Biomedical Inc | Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
US6025468A (en) | 1998-06-20 | 2000-02-15 | United Biomedical, Inc. | Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
DE19856052A1 (de) * | 1998-12-04 | 2000-06-08 | Deutsches Krebsforsch | Konjugat zur Anreicherung in neuronalen Zellen |
US6663861B2 (en) | 2000-11-09 | 2003-12-16 | Antibodyshop A/S | Method of producing antibodies by immunization with conjugates of molecules coupled to charge-modified proteins |
JP5667062B2 (ja) | 2008-10-10 | 2015-02-12 | エラ、ビオテック、ソシエダッド、アノニマEra Biotech, S.A. | 免疫原特異的アジュバントとしての組換えタンパク粒 |
CA2756170C (fr) * | 2009-03-23 | 2019-04-02 | The Brigham And Women's Hospital, Inc. | Vaccins glycoconjugues |
EP2418284A1 (fr) | 2010-08-13 | 2012-02-15 | ERA Biotech, S.A. | Séquences de polypeptides induisant le corps protéiques |
EP2870974A1 (fr) * | 2013-11-08 | 2015-05-13 | Novartis AG | Vaccins conjugués de salmonelle |
US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
JP7186166B2 (ja) | 2016-12-30 | 2022-12-08 | バックスサイト・インコーポレイテッド | 非天然アミノ酸とのポリペプチド抗原接合体 |
US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
AU2019299836A1 (en) | 2018-07-04 | 2021-02-25 | Vaxcyte, Inc. | Improvements in immunogenic conjugates |
WO2020010016A1 (fr) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Conjugués immunogènes auto-adjuvés |
WO2020010000A1 (fr) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Procédés améliorés pour la préparation de conjugués immunogènes |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0172107A1 (fr) * | 1984-08-10 | 1986-02-19 | Praxis Biologics, Inc. | Conjugués immunogènes d'unité secondaire d'entérotoxine LT-B d'E. coli et polymères capsulaires |
EP0186576A2 (fr) * | 1984-12-20 | 1986-07-02 | Merck & Co. Inc. | Polysaccharides bactériens neutres modifiés de manière covalente, conjugés stables covalents entre ces polysaccharides et des protéines immunogéniques et méthodes de préparation de ces polysaccharides et conjugués |
EP0245045B1 (fr) * | 1986-05-05 | 1993-11-03 | Praxis Biologics, Inc. | Conjugués immunogènes |
-
1989
- 1989-01-31 AU AU30654/89A patent/AU634153B2/en not_active Ceased
- 1989-01-31 WO PCT/US1989/000388 patent/WO1989006974A2/fr active IP Right Grant
- 1989-01-31 JP JP1502396A patent/JP2921574B2/ja not_active Expired - Fee Related
- 1989-01-31 DE DE68917126T patent/DE68917126T2/de not_active Expired - Fee Related
- 1989-01-31 EP EP89908669A patent/EP0399001B1/fr not_active Expired - Lifetime
- 1989-01-31 AT AT89908669T patent/ATE109008T1/de not_active IP Right Cessation
- 1989-02-01 CA CA000616882A patent/CA1340958C/fr not_active Expired - Fee Related
- 1989-02-01 CA CA000589806A patent/CA1340956C/fr not_active Expired - Fee Related
-
1990
- 1990-06-29 FI FI903292A patent/FI104374B/fi not_active IP Right Cessation
- 1990-06-29 NO NO902909A patent/NO179164C/no not_active IP Right Cessation
- 1990-07-31 DK DK199001829A patent/DK174416B1/da not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0172107A1 (fr) * | 1984-08-10 | 1986-02-19 | Praxis Biologics, Inc. | Conjugués immunogènes d'unité secondaire d'entérotoxine LT-B d'E. coli et polymères capsulaires |
EP0186576A2 (fr) * | 1984-12-20 | 1986-07-02 | Merck & Co. Inc. | Polysaccharides bactériens neutres modifiés de manière covalente, conjugés stables covalents entre ces polysaccharides et des protéines immunogéniques et méthodes de préparation de ces polysaccharides et conjugués |
EP0245045B1 (fr) * | 1986-05-05 | 1993-11-03 | Praxis Biologics, Inc. | Conjugués immunogènes |
Non-Patent Citations (9)
Title |
---|
Infection and Immunity, vol. 55, no. 11, November 1987, American Society for Microbiology (US), L.D. Lise et al.: "Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier", pages 2658-2661 * |
Infection and Immunity, vol. 55, no. 6, June 1987, American Society for Micro-biology (US), M.E. Jolivet et al.: "Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier", pages 1498-1502 * |
Nature, vol. 300, 12 November 1987, M.J. Francis et al.: "Non-responsiveness to a foot and mouth disease virus peptide overcome by addition of foreign helper T-cell determinants ", pages 168-170 * |
Nucleic Acids Research, vol. 14, no. 19, 19 November 1986, IRL Press Ltd (Oxford, GB), N.F. Fairweather et al.: "The complete nucleotide sequence of tetanus toxin", pages 7809-7812 * |
Proceedings of the National Academy of Sciences of the USA, vol. 80, no. 22, November 1983, L. Greenfield et al.: "Nucleotide sequence of the structural gene for diptheria toxin carried by coryne-bacteriophage beta", pages 6853-6857 * |
Science, vol. 235, 27 February 1987, M.F. Good et al.: "Construction of synthetic immunogen: use of new T-helper epitome on malaria circum-sporoziteprotein", pages 1059-1062 * |
The European Journal of Immunology, vol. 16, 1986,, VCH Verlagsgesellschaft mbh, (Weinheim, DE), F. Triebel et al.: "Immune response to diptheria toxin and to different CNBr fragments: evidence for different B and T cell reactivities", pages47-53 * |
The Journal of Immunology, vol. 138, no. 12, 15 June 1987, The American Association of Immunologists (US), D.R. Milich et al.: "A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg", pages 4457 -4465 * |
The Journal of Immunology, vol. 142, no. 2, 15 January 1989, The American Association of Immunologists (US), S. Demotz et al.: "Delineation of several DR-restricted tetanus toxin T cell epitopes", pages 394-402 * |
Also Published As
Publication number | Publication date |
---|---|
DK182990D0 (da) | 1990-07-31 |
CA1340956C (fr) | 2000-04-11 |
AU634153B2 (en) | 1993-02-18 |
DE68917126D1 (de) | 1994-09-01 |
AU3065489A (en) | 1989-08-25 |
EP0399001B1 (fr) | 1994-07-27 |
FI104374B (fi) | 2000-01-14 |
NO902909L (no) | 1990-08-27 |
DE68917126T2 (de) | 1995-02-02 |
NO179164C (no) | 1996-08-21 |
ATE109008T1 (de) | 1994-08-15 |
JPH03502691A (ja) | 1991-06-20 |
WO1989006974A2 (fr) | 1989-08-10 |
DK182990A (da) | 1990-07-31 |
DK174416B1 (da) | 2003-02-17 |
NO179164B (no) | 1996-05-13 |
JP2921574B2 (ja) | 1999-07-19 |
EP0399001A1 (fr) | 1990-11-28 |
CA1340958C (fr) | 2000-04-11 |
NO902909D0 (no) | 1990-06-29 |
FI903292A0 (fi) | 1990-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1989006974A3 (fr) | Epitopes de cellules t a titre de molecules porteuses pour vaccins conjugues | |
CA2188284C (fr) | Compositions de polysaccharides de streptocoques du groupe a ayant des proprietes immunogenes et procedes associes | |
RU95105991A (ru) | Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации | |
IL104696A0 (en) | Dual carrier immunogenic construct and a vaccine containing the same | |
HK1143950A1 (en) | Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens | |
WO1998058668A3 (fr) | VACCIN CONTENANT UN ANTIGENE DE $i(BORDETELLA PERTUSSIS) | |
GR3015791T3 (en) | Synthetic peptides useful as universal carriers for the preparation of immunogenic conjugates and their use in the development of synthetic vaccines. | |
NO974727L (no) | Immunogene og immunostimulatoriske oligosakkarid sammensetninger og fremgangsmåter for fremstilling derav | |
WO2001079259A8 (fr) | Complexation d'antigenes proteiques et de proteines de stress par sequence javelot | |
WO1999052548A3 (fr) | Vaccins conjugues pour la prevention contre les caries dentaires | |
EP0338265A3 (en) | Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine | |
US6165468A (en) | Antigenic carbohydrate linked to an immunogenic carrier | |
RU93048161A (ru) | Комбинированная педиатрическая вакцина с усиленной иммуногенностью каждого вакционного компонента | |
IL107387A (en) | Combination pediatric vaccine with enhanced immunogenicity of each vaccine component | |
ZA856655B (en) | Cross-reactive and protective epitopes of circumsporozoite proteins | |
AU7547987A (en) | Method of preparation and use for feline leukemia virus antigens | |
Michon et al. | Combination conjugate vaccines against multiple serotypes of group B streptococci | |
CA2133108A1 (fr) | Vaccin a base de toxoide contre pasteurella haemolytica type a-1 | |
WO1990015132A3 (fr) | Gene endoflagellaire clone de treponema hyodysenteriae |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU DK FI JP NO |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU DK FI JP NO |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 903292 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1989908669 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1989908669 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1989908669 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 903292 Country of ref document: FI |